INTEGRA Biosciences and Viaflo Corporation Join Forces
News Aug 18, 2009
The combining of the two companies provides for strong mutual benefits. INTEGRA Biosciences will be receiving direct access to the important US Market through the Viaflo sales network. INTEGRA Biosciences also receives access to a complete line of new and innovative handheld pipetting systems and associated plastic disposables. Viaflo will receive strong representation and access to European and global markets through INTEGRA Biosciences and their large network of specialist distributors. In the USA - Viaflo will also benefit from selling the complimentary, well recognised, and established INTEGRA Biosciences product portfolio. The INTEGRA Biosciences and Viaflo products complement each other perfectly.
The new group, in the last 2 years has translated customer needs into the introduction of many new innovative and reliable products. With specialists in sales, marketing, research, development and manufacturing it maintains close relations and collaborations with customers worldwide for the purpose of providing cutting edge technologies to the health care industry.
As a result of constant growth achieved over recent years, INTEGRA Biosciences has announced that it will also move from its current location into a larger new modern industrial building in Zizers, Switzerland.
What’s in Your Wheat? Sequencing One of the Most Complex Genomes Known to ScienceNews
The wheat genome sequences may help biologists not only better understand the evolutionary history of wheat, but also advance the quest for hardier, more pest- and drought-resistant wheat types to help feed the world’s growing population.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE